Thresholds of Genotoxic and Non-Genotoxic Carcinogens

• Published in: Toxicological research (Seoul) Vol. 34; no. 4; pp. 281 - 290
• Main Author: Nohmi, Takehiko
• Format: Journal Article
• Language: English
• Published: Singapore 한국독성학회 01-10-2018; Springer Singapore; Korean Society of Toxicology
• Subjects: Biomedicine; Invited Review; Pharmacology/Toxicology; 예방의학; Threshold of toxicological concern; TTC; Non-genotoxic carcinogens; Genotoxic carcinogens; Threshold
• ISSN: 1976-8257; 2234-2753
• DOI: 10.5487/tr.2018.34.4.281

Exposure to chemical agents is an inevitable consequence of modern society; some of these agents are hazardous to human health. The effects of chemical carcinogens are of great concern in many countries, and international organizations, such as the World Health Organization, have established guidelines for the regulation of these chemicals. Carcinogens are currently categorized into two classes, genotoxic and non-genotoxic carcinogens, which are subject to different regulatory policies. Genotoxic carcinogens are chemicals that exert carcinogenicity via the induction of mutations. Owing to their DNA interaction properties, there is thought to be no safe exposure threshold or dose. Genotoxic carcinogens are regulated under the assumption that they pose a cancer risk for humans, even at very low doses. In contrast, non-genotoxic carcinogens, which induce cancer through mechanisms other than mutations, such as hormonal effects, cytotoxicity, cell proliferation, or epigenetic changes, are thought to have a safe exposure threshold or dose; thus, their use in society is permitted unless the exposure or intake level would exceed the threshold. Genotoxicity assays are an important method to distinguish the two classes of carcinogens. However, some carcinogens have negative results in
in vitro
bacterial mutation assays, but yield positive results in the
in vivo
transgenic rodent gene mutation assay. Non-DNA damage, such as spindle poison or topoisomerase inhibition, often leads to positive results in cytogenetic genotoxicity assays such as the chromosome aberration assay or the micronucleus assay. Therefore, mechanistic considerations of tumor induction, based on the results of the genotoxicity assays, are necessary to distinguish genotoxic and non-genotoxic carcinogens. In this review, the concept of threshold of toxicological concern is introduced and the potential risk from multiple exposures to low doses of genotoxic carcinogens is also discussed.